about
Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesisThe clinical and genetic heterogeneity of paroxysmal dyskinesias.Dystonic opisthotonus: a "red flag" for neurodegeneration with brain iron accumulation syndromes?Transducer-based evaluation of tremor.Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiencyPRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's diseaseDystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.Ability to cycle despite severe freezing of gait in atypical parkinsonism in Fahr's syndrome.Ataxia telangiectasia presenting as dopa-responsive cervical dystonia.The entity of parkinsonism and associated lipomatosis.Progressive ataxia and palatal tremor associated with dense pontine calcification: A unique case.Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease.Psychogenic palatal tremor may be underrecognized: reappraisal of a large series of casesADCY5 mutations are another cause of benign hereditary choreaParkinson's disease in GTP cyclohydrolase 1 mutation carriers.The phenotypic spectrum of DYT24 due to ANO3 mutations.Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation.Atypical parkinsonism: an update.Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel.Movement disorders on YouTube--caveat spectatorMutations in HPCA cause autosomal-recessive primary isolated dystoniaReward Pays the Cost of Noise Reduction in Motor and Cognitive Control.THAP1 mutations and dystonia phenotypes: genotype phenotype correlations.Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.Rational therapeutic approaches to progressive supranuclear palsy.Dopaminergic reward system: a short integrative review.Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases.Functional movement disorders are not uncommon in the elderly."Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.The expanding universe of disorders of the basal ganglia.The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.Atypical parkinsonism: diagnosis and treatment.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Multiple system atrophy-mimicking conditions: Diagnostic challenges.Interventions in progressive supranuclear palsy.From a single nucleotide polymorphism to tau pathology: Appoptosin is the missing link.Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials.Which ante mortem clinical features predict progressive supranuclear palsy pathology?Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
P50
Q24602504-9F3D3FB4-4886-4895-B9CB-C95799B5275AQ26776399-32F5AC66-54FF-491C-B880-900D867FF5AFQ27005740-421A041D-92A5-40E8-8609-50010C8E1C01Q30249764-480F3ACA-A8F3-4757-A2AA-A06D3338B700Q30419465-4F46AD15-F961-4C01-B19E-24EB48AA4021Q30528874-3EF39BE7-EFCF-4805-8842-3EE5DB18EE40Q30529759-45C123E7-2F68-432A-A664-5799BBA786ACQ30540080-2D9FB90E-3A6C-48A7-8265-0FE54C6965A6Q30540295-D40FA923-DB23-4BEA-8880-9CEA47ACB3D8Q30550130-B5AF5CD9-C90B-444A-A22D-820DF9144271Q30597045-DE136DAA-1EBE-4FF8-B444-33C19E2EA939Q30598870-56B22CA5-9A2B-472D-90C9-B1FE58543439Q30598892-510C7FB9-5354-483C-B2DB-1CA60D2C21F7Q30598905-513221BF-7101-4862-9334-D51B075F1815Q30657722-81912A5A-A7B5-403E-ACD9-E7433D771CBFQ34044060-A3CE53B0-AF4B-4E70-997E-B8363543EEEFQ34114507-EB915CB1-6E9B-4122-8A6F-67524577916FQ34320989-823B0761-2D6F-4451-822A-AF200C8C9B26Q34337714-66037A43-0496-49D5-8096-6F23E5D96BADQ34398504-8D37561B-16D5-4677-95D8-EA956805AD51Q34502846-A5DAC200-CC4C-4545-AA37-C99A75163BC4Q35266327-E4B19EEB-249F-4750-9454-6804C6BFBE1DQ36019926-3D1F403D-5D58-4961-9D05-A6A0A27B4A3EQ36876895-692C7DA4-8BB6-48EF-8D2F-12F1DE0B4F8DQ37621250-61262E16-4270-4A7A-8E3B-816972863E43Q37753509-301B86A8-D678-4B03-BDC6-C2DF5E88C9B9Q37798319-7F21D3F2-091A-4EF4-A103-7420CC4EBC5FQ38006910-0D35C69B-4070-491F-8754-D642F8F8A725Q38082498-D3121CA2-B611-4BB7-9970-C4196BE770BAQ38110488-0F193A7E-4754-4AEC-9087-54F41518FE35Q38222396-48A7BE64-B61C-461A-BBD6-821BD738E72FQ38265061-EEA1A650-FBF6-4501-9DC6-DE92F306A83AQ38272505-71C29850-5331-4697-8D94-E379A1D0D6F3Q38492560-9C04975E-4A52-4E36-948C-77620EBE35EFQ38586159-5A6AAE28-04CF-4547-9DF6-D3EA02DFB671Q38605433-897E7033-DEB3-4726-8A1C-9E31BDE9BA13Q38632937-4D08785A-A367-4DDC-BF07-AFF0AB552236Q38691690-E7EE4CB5-A256-4D15-AA35-FB8037E4C7D0Q38788274-E877BDDE-B9A4-4A0F-BDD9-A30166546BD8Q38807324-9283DC30-2E4D-4B7B-BC8B-A9D56682605C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria Stamelou
@ast
Maria Stamelou
@en
Maria Stamelou
@es
Maria Stamelou
@nl
type
label
Maria Stamelou
@ast
Maria Stamelou
@en
Maria Stamelou
@es
Maria Stamelou
@nl
altLabel
Stamelou M
@en
prefLabel
Maria Stamelou
@ast
Maria Stamelou
@en
Maria Stamelou
@es
Maria Stamelou
@nl
P214
P106
P214
P31
P4012
P496
0000-0003-1668-9925
P735
P7859
viaf-90851050